Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EDNRB | P24530 | 12/20 | 0.62 |
| ▸ | EDNRA | P25101 | 8/20 | 0.56 |
| ▸ | TP53 | P04637 | 2/20 | 0.38 |
| ▸ | POLB | P06746 | 2/20 | 0.38 |
| ▸ | PLA2G2A | P14555 | 2/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8549596 | 0.90 | EDNRB (0.57) | EDNRBEDNRAPLA2G2A | |
| SCHEMBL8552564 | 0.90 | EDNRB (0.66) | EDNRBEDNRATP53POLB | |
| SCHEMBL8550267 | 0.89 | EDNRB (0.77) | EDNRBEDNRAMAPT | |
| SCHEMBL8548416 | 0.88 | EDNRB (0.50) | EDNRBEDNRATP53POLBPLA2G2A | |
| SCHEMBL8550955 | 0.88 | EDNRB (0.81) | EDNRBEDNRATP53POLBMAPT | |
| SCHEMBL8550227 | 0.87 | EDNRB (0.58) | EDNRBEDNRATP53POLBMAPT | |
| SCHEMBL8546347 | 0.86 | EDNRB (0.66) | EDNRBEDNRA | |
| SCHEMBL8547198 | 0.85 | EDNRB (0.55) | EDNRBEDNRATP53PLA2G2AMAPT | |
| SCHEMBL8548078 | 0.85 | EDNRB (0.60) | EDNRBEDNRATP53POLBMAPT | |
| SCHEMBL8549315 | 0.84 | EDNRB (0.64) | EDNRBEDNRATP53POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0863898-A1 | ENDOTHELIN RECEPTOR ANTAGONISTS | MERCK PATENT GmbH (DE) | 1998-09-16 | — | — | EP | disclosed |
| WO-1997019077-A1 | ENDOTHELIN RECEPTOR ANTAGONISTS | MERCK Patent Gesellschaft mit beschränkter Haftung (DE) | 1997-05-29 | — | — | WO | disclosed |